The characterization of the molecular underpinnings of MPIS and mitophagy regulation by NLRX1 will provide opportunities to rationally design novel therapeutics aiming at improving mitochondrial function, which may be of critical importance for numerous pathologies, including neurodegenerative diseases, cancer, cardiac and inflammatory diseases. The gene discussed is NLRX1; the disease is cancer.